EI

270.6

-0.11%↓

MRK1

107.55

+0.99%↑

SAN

79.42

+0.88%↑

SHL.DE

47.3

-0.65%↓

UCB

203.7

-0.05%↓

EI

270.6

-0.11%↓

MRK1

107.55

+0.99%↑

SAN

79.42

+0.88%↑

SHL.DE

47.3

-0.65%↓

UCB

203.7

-0.05%↓

EI

270.6

-0.11%↓

MRK1

107.55

+0.99%↑

SAN

79.42

+0.88%↑

SHL.DE

47.3

-0.65%↓

UCB

203.7

-0.05%↓

EI

270.6

-0.11%↓

MRK1

107.55

+0.99%↑

SAN

79.42

+0.88%↑

SHL.DE

47.3

-0.65%↓

UCB

203.7

-0.05%↓

EI

270.6

-0.11%↓

MRK1

107.55

+0.99%↑

SAN

79.42

+0.88%↑

SHL.DE

47.3

-0.65%↓

UCB

203.7

-0.05%↓

Search

Carl Zeiss Meditec AG

Gesloten

SectorGezondheidszorg

44.02 2.61

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

42.8

Max

44.22

Belangrijke statistieken

By Trading Economics

Inkomsten

-17M

28M

Verkoop

-10M

550M

K/W

Sectorgemiddelde

25.088

35.293

EPS

0.52

Winstmarge

5.163

Werknemers

5,730

EBITDA

-25M

48M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+21.67% upside

Dividenden

By Dow Jones

Volgende Winsten

11 dec 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

86M

3.8B

Vorige openingsprijs

41.41

Vorige sluitingsprijs

44.02

Nieuwssentiment

By Acuity

40%

60%

152 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Carl Zeiss Meditec AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

28 okt 2024, 11:15 UTC

Marktinformatie
Winsten

Med-Tech Stocks Drop Amid Subdued Demand in China -- Market Talk

Peer Vergelijking

Prijswijziging

Carl Zeiss Meditec AG Prognose

Koersdoel

By TipRanks

21.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 52.44 EUR  21.67%

Hoogste 68 EUR

Laagste 45 EUR

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Carl Zeiss Meditec AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

4

Buy

6

Hold

1

Sell

Technische score

By Trading Central

58.75 / 60.35Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

152 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
help-icon Live chat